Patents Assigned to Hess Pharmaceuticals, Inc.
  • Selenium-Based Compositions and Therapeutic Methods
    Publication number: 20230218659
    Abstract: This invention provides selenium-based methods for treating refractory anemia with ring sideroblasts (RARS), cancer characterized by one or more genetic mutations associated with ring sideroblasts, and porphyria. This invention also provides related prophylactic methods, and articles of manufacture.
    Type: Application
    Filed: May 19, 2021
    Publication date: July 13, 2023
    Applicant: Hess Pharmaceuticals, Inc.
    Inventor: Jacob S.J. Hess